MAI Capital Management’s Lipella Pharmaceuticals LIPO Stock Holding History

MAI Capital Management’s Portfolio LIPO Stock Details LIPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-125	Closed	-$314	–	4011
2025 Q1	$314	Hold	125	–	–	﹤0.01%	3275
2024 Q4	$382	Buy	+125	New	+$379	﹤0.01%	3322

MAI Capital Management's LIPO Position: Q2 2025 in Review

MAI Capital Management sold out of Lipella Pharmaceuticals (LIPO) in Q2 2025, closing a stake of 125 shares — an estimated $314 sold.

MAI Capital Management first reported a position in LIPO in Q4 2024 and held it in 2 quarters. The position peaked at $382 in Q4 2024. 0 funds tracked by Wall St. Rank hold LIPO as of Q2 2025.

MAI Capital Management reported no remaining Lipella Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
MAI Capital Management sold 125 Lipella Pharmaceuticals shares in Q2 2025, an estimated $314.
MAI Capital Management first reported a position in Lipella Pharmaceuticals in Q4 2024 and held it in 2 quarters.
MAI Capital Management's Lipella Pharmaceuticals position peaked at $382 in Q4 2024.
0 funds tracked by Wall St. Rank held Lipella Pharmaceuticals as of Q2 2025.

Based on MAI Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.